Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/14/2003WO2002064630A3 Il-1 receptor accessory protein
08/14/2003WO2002059366A3 Rna polymers and uses thereof
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002057479A3 Primers and methods for the detection and discrimination of nucleic acids
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002057437A3 Generation of human cytomegalovirus yeast artificial chromosome recombinants
08/14/2003WO2002055735A3 Compositions and methods relating to prostate specific genes and proteins
08/14/2003WO2002055560A3 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
08/14/2003WO2002052036A3 Identification of modulators of dham-kinase and inflammatory diseases
08/14/2003WO2002050117A3 G-proteins coupled receptor proteins and nucleic acids encoding same
08/14/2003WO2002048377A3 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
08/14/2003WO2002048342A3 Knockout mice for trp6 gene
08/14/2003WO2002047718A3 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia)
08/14/2003WO2002046415A3 Polynucleotide and polypeptide sequences of putative transporters and ion channells
08/14/2003WO2002044427A3 Cell based triple readout assay systems for identifying compounds that effect transcription
08/14/2003WO2002039116A3 Retrovirus isolated from humans
08/14/2003WO2002038751A3 Ras/p21 transgenic mouse
08/14/2003WO2002038601A3 Foggy
08/14/2003WO2002036760A3 Methods for expressing endogenous genes by restriction enzyme mediated integration
08/14/2003WO2002036632A3 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides
08/14/2003WO2002034947A3 Detecting specific nucleotide sequences
08/14/2003WO2002034774A3 Bacillus thuringiensis proteins and variants thereof with pesticidal activity against coleopterans
08/14/2003WO2002033060A3 Nucleic acid sequences to proteins involved in tocopherol synthesis
08/14/2003WO2002031130A9 Manipulation of soluble carbohydrates
08/14/2003WO2002029117A3 Methods and probes for detection and/or quantification of nucleic acid sequences
08/14/2003WO2002029070A3 Genetic functions required for gene silencing in maize
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003WO2002026933A9 Isoprenoid production
08/14/2003WO2002026779A3 A fibrin/fibrinogen-binding conjugate
08/14/2003WO2002024887A3 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002020733A3 Genes involved in isoprenoid compound production
08/14/2003WO2002020051A3 Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments
08/14/2003WO2002018609A9 Methods for stable transduction of cells with viral vectors
08/14/2003WO2002016584A3 Process for the preparation of neutrophil inhibitory factor
08/14/2003WO2002012497A3 Haplotypes of the nfkbib gene
08/14/2003WO2002012335A3 A NEW EGF MOTIF REPEAT PROTEIN OBTAINED FROM A cDNA LIBRARY FROM HS-5 STROMAL CELL LINE
08/14/2003WO2002010453A3 Molecular toxicology modeling
08/14/2003WO2002009295A3 Plant acyl-coa synthetases
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2002003787A3 Transgenic mice containing targeted gene disruptions
08/14/2003WO2002000705A3 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells
08/14/2003WO2001098539A3 Gene markers for lung cancer
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001092292A3 Ghrelin analogs
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003WO2001088196A3 Sequence based screening
08/14/2003WO2001077176A3 E.coli blr molecules affecting antibiotic susceptibility
08/14/2003WO2001055198A9 Dermo- and gastro-specific sphingolipid activator
08/14/2003US20030154518 Such as EPSP synthases from plant cells; homologous recombination
08/14/2003US20030154517 Efficiency agrobacterium-mediated wheat transformation method
08/14/2003US20030154516 Cotton alpha-globulin promoter for seed-specific expression of transgenes
08/14/2003US20030154515 Triacylglycerol lipases
08/14/2003US20030154513 Which are associated with tocopherol biosynthesis; for addition to feedstocks
08/14/2003US20030154512 Sugar and lipid metabolism regulators in plants III
08/14/2003US20030154511 Plant retroviral polynucleotides and methods for use thereof
08/14/2003US20030154510 Novel delta-endotoxin gene isolated from Bacillus thuringiensis var. finitimus
08/14/2003US20030154509 Control of gene expression in plants
08/14/2003US20030154507 Comprises DNA that codes for enzyme which degrades 2,4-dichlorophenoxyacetic acid to dichlorophenol; weed control; auxins
08/14/2003US20030154505 Transgenic non-human mammal with an oncogenic mutant of the c-Raf-1 gene
08/14/2003US20030154504 Methods and compositions for modulating carbohydrate metabolism
08/14/2003US20030154503 Cathepsin G (CTSG) disruptions, compositions and methods relating thereto
08/14/2003US20030154500 Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
08/14/2003US20030154499 Gene knockout; membrane proteins; lymphocytes; very low antigen (VLA-4) receptors
08/14/2003US20030154035 Simulation of gene expression control using connectrons, interference RNAs (iRNAs) and small temporal RNAs (stRNAs) in prokaryotic, archea and eukaryotic genomes
08/14/2003US20030153740 Cloning libraries with probe which comprises hepatitis B virus (HBV); hap proteins
08/14/2003US20030153739 Formed via cloning and expressing cDNA, then detecting missense mutations with immunoassay
08/14/2003US20030153738 Homologs of bacterial AlkB gene (hABH); receptor binding assay; for repairing alkylated DNA, preventing/treating cell death/cancer
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153731 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
08/14/2003US20030153527 Infecting animal cells with live invasive bacteria containing a eukaryotic expression cassette encoding gene, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense RNA or a catalytic RNA
08/14/2003US20030153526 Compositions contain antisense oligonucleotides that hybridize to Grb2 and Crkl nucleic acids, gene products of which are known to interact with tumorigenic protein bcr-abl
08/14/2003US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153521 Nucleic acid treatment of diseases or conditions related to levels of Ras
08/14/2003US20030153520 Inside cells, such as those involving fusion events and in particular those involving exocytic events, in particular relates to positive and negative regulation of any tetanus neurotoxin (TeNT)-resistant pathway inside a cell
08/14/2003US20030153519 Drug delivering a nucleic acid and an RNase inhibitor to a target cell of a vascularized multi-cellular organism; RNA interference
08/14/2003US20030153518 Activation and inhibition of the immune system
08/14/2003US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153090 Such as acetoxymethyl diacetyl-coelenterazine, which is contacted with luciferase
08/14/2003US20030153083 Permitting anti-sense RNA to hybridize with an RNA transcribed from the locus in the targeted population so as to form a contiguous double stranded RNA for interacting with double stranded RNA dependent protein kinase
08/14/2003US20030153081 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/14/2003US20030153076 Mammalian telomerase
08/14/2003US20030153075 TGF-beta-specific covalently closed antisense molecule
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required
08/14/2003US20030153065 A formulation for maintaining a non-enveloped viral vector containing: trehalose, magnesium chloride, a cationic polymer or a combination, a multiple of non-enveloped viral vector particles and a liquid carrier
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153058 A gene coding for glutamate dehydrogenase is introduced into a microorganism having L-arginine producing ability to enhance intracellular glutamate dehydrogenase activity and thereby improve the L-arginine producing ability
08/14/2003US20030153057 Method for l-threonine production
08/14/2003US20030153055 Cell-free subcloning system utilizing three elements: a donor vector; an acceptor vector; and site- specific recombinase that recognizes the site-specific recombination sequence in the donor and acceptor vectors
08/14/2003US20030153054 Methods and compositions for use in spliceosome mediated RNA trans-splicing
08/14/2003US20030153053 Methods for altering polyketide synthase genes
1 ... 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 ... 4023